Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Mol Endocrinol ; 13(9): 1535-49, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10478844

ABSTRACT

The peroxisome proliferator-activated receptor alpha (PPARalpha) plays a key role in lipid and lipoprotein metabolism. However, important inter- and intraspecies differences exist in the response to PPARalpha activators. This incited us to screen for PPARalpha variants with different signaling functions. In the present study, using a RT-PCR approach a variant human PPARalpha mRNA species was identified, which lacks the entire exon 6 due to alternative splicing. This deletion leads to the introduction of a premature stop codon, resulting in the formation of a truncated PPARalpha protein (PPARalphatr) lacking part of the hinge region and the entire ligand-binding domain. RNase protection analysis demonstrated that PPARalphatr mRNA is expressed in several human tissues and cells, representing between 20-50% of total PPARalpha mRNA. By contrast, PPARalphatr mRNA could not be detected in rodent tissues. Western blot analysis using PPARalpha-specific antibodies demonstrated the presence of an immunoreactive protein migrating at the size of in vitro produced PPARalphatr protein both in human hepatoma HepG2 cells and in human hepatocytes. Both in the presence or absence of 9-cis-retinoic acid receptor, PPARalphatr did not bind to DNA in gel shift assays. Immunocytochemical analysis of transfected CV-1 cells indicated that, whereas transfected PPARalphawt was mainly nuclear localized, the majority of PPARalphatr resided in the cytoplasm, with presence in the nucleus depending on cell culture conditions. Whereas a chimeric PPARalphatr protein containing a nuclear localization signal cloned at its N-terminal localized into the nucleus and exhibited strong negative activity on PPARalphawt transactivation function, PPARalphatr interfered with PPARalphatr transactivation function only under culture conditions inducing its nuclear localization. Cotransfection of the coactivator CREB-binding protein relieved the transcriptional repression of PPARalphawt by PPARalphatr, suggesting that the dominant negative effect of PPARalphatr might occur through competition for essential coactivators. In addition, PPARalphatr interfered with transcriptional activity of other nuclear receptors such as PPARgamma, hepatic nuclear factor-4, and glucocorticoid receptor-alpha, which share CREB-binding protein/p300 as a coactivator. Thus, we have identified a human PPARalpha splice variant that may negatively interfere with PPARalphawt function. Factors regulating either the ratio of PPARalphawt vs. PPARalphatr mRNA or the nuclear entry of PPARalphatr protein should therefore lead to altered signaling via the PPARalpha and, possibly also, other nuclear receptor pathways.


Subject(s)
RNA Splicing , Receptors, Cytoplasmic and Nuclear/genetics , Transcription Factors/genetics , Animals , Apolipoprotein A-II/genetics , Apolipoprotein A-II/metabolism , Base Sequence , Binding Sites , COS Cells , Cell Line , Cyclic AMP Response Element-Binding Protein/genetics , Cyclic AMP Response Element-Binding Protein/metabolism , Gene Expression , Gene Expression Regulation , Humans , Mice , Molecular Sequence Data , Nuclear Proteins/metabolism , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Receptors, Cytoplasmic and Nuclear/metabolism , Repressor Proteins/metabolism , Sequence Homology, Nucleic Acid , Tissue Distribution , Transcription Factors/metabolism , Transcription, Genetic , Tumor Cells, Cultured
2.
J Biol Chem ; 272(36): 22401-4, 1997 Sep 05.
Article in English | MEDLINE | ID: mdl-9278389

ABSTRACT

Since elevated concentrations of plasma high density lipoprotein (HDL) and its major apolipoprotein (apo), apoA-I, confer protection against atherosclerosis, considerable research efforts have focussed on the identification of factors regulating apoA-I gene expression in an attempt to increase its production. Nuclear receptors are interesting candidates because they are transcription factors whose activity is ligand-dependent. In the present study we identified the orphan receptor RORalpha1 as an activator of apoA-I gene transcription. In apoA-I-expressing intestinal Caco-2 cells, overexpression of the RORalpha1, but not the RORalpha2 or RORalpha3 isoforms, increased rat apoA-I gene transcription. Deletion and site-directed mutagenesis experiments identified a functional ROR-responsive element (RORE) in the rat and mouse apoA-I gene promoters, which overlaps with the TATA box. Gel shift experiments indicated that this RORE binds the RORalpha1 isoform, but not the RORalpha2 or RORalpha3 isoforms. Furthermore, compared with wild type mice, apoA-I mRNA levels were significantly lower in small intestines of staggerer mice homozygous for a deletion in the RORalpha gene. In addition, reverse transcriptase-polymerase chain reaction analysis revealed the expression of RORalpha in small intestinal epithelium and in Caco-2 cells. These data indicate a novel, physiological role for RORalpha1 in the regulation of genes involved in lipid and lipoprotein metabolism and possibly in the development of metabolic diseases, such as atherosclerosis.


Subject(s)
Apolipoprotein A-I/genetics , Gene Expression Regulation , Receptors, Cytoplasmic and Nuclear/physiology , Animals , Caco-2 Cells , Cell Line , Chlorocebus aethiops , Humans , Mice , Promoter Regions, Genetic , Rats , Recombinant Proteins/genetics , Transcription, Genetic
3.
Immunobiology ; 198(1-3): 307-31, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9442402

ABSTRACT

Nuclear dots (NDs), alternatively designated nuclear bodies (NBs), PML oncogenic domains (PODs), nuclear domain 10 (ND10) or Kr-bodies, became a major topic for researchers in many fields only recently. Originally described as an autoantigenic target in patients with primary biliary cirrhosis, they are now also known to play a role in development of acute promyelocytic leukemia (APL) and possibly other forms of neoplasia. Size, number and composition of NDs are regulated throughout the cell cycle. Infection with herpes simplex virus, adenovirus, cytomegalovirus, Epstein-Barr-virus, influenza virus and human T cell lymphotropic virus type I (HTLV I) strongly modifies ND structure through viral regulatory proteins. Due to this finding and because at least three of the cellular ND proteins are highly interferon-inducible, a function of NDs in early viral infection or in antiviral response has been postulated. Functional data are currently available only for two of the ND-associated proteins. The Sp100 protein seems to have transcriptional transactivating property, whereas the promyelocytic leukemia protein (PML) was reported to suppress growth and transformation. Here, we give a brief overview of the data currently available on NDs. Thus, we hope to link seemingly unrelated findings in the literature on oncology, virology, cell biology and immunology.


Subject(s)
Antigens, Nuclear , Autoantigens/metabolism , Neoplasm Proteins/metabolism , Nuclear Proteins/metabolism , Transcription Factors/metabolism , Animals , Autoantigens/biosynthesis , Autoantigens/genetics , Binding Sites , Cell Compartmentation , Cell Nucleus/metabolism , Gene Expression , Humans , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Nuclear Proteins/biosynthesis , Nuclear Proteins/genetics , Promyelocytic Leukemia Protein , Transcription Factors/biosynthesis , Transcription Factors/genetics , Tumor Suppressor Proteins
4.
J Biol Chem ; 271(41): 25253-60, 1996 Oct 11.
Article in English | MEDLINE | ID: mdl-8810287

ABSTRACT

Expression of the nuclear domain-associated proteins Sp100, PML, and NDP52, is enhanced by interferons (IFNs) on the mRNA and protein level. Increase both of Sp100 and PML mRNA is due to enhanced transcription of the corresponding genes which occurs independently of cellular protein synthesis immediately upon IFN-beta addition. Here, we describe the molecular cloning and functional analysis of the Sp100 promoter. DNA sequence analysis revealed potential binding sites for several constitutive and IFN-inducible transcription factors. Consistent with the absence of a TATA box and an initiator element, several transcription initiation sites were found. Transient expression studies identified an imperfect IFN-stimulated response element within the first 100 nucleotides upstream of the major transcription start site. This element rendered a heterologous promoter IFN-beta-inducible and bound IFN-stimulated gene factor 2 strongly but IFN-stimulated gene factor 3 only weakly. An IFN-gamma activation site approximately 500 base pairs upstream of the IFN-stimulated response element was found to bind three IFN-alpha/beta activation factors upon IFN-beta induction and conferred both type I and type II IFN inducibility upon a heterologous promoter. These data demonstrate a novel arrangement of a nonoverlapping IFN-gamma activation site and an IFN-stimulated response element mediating type I IFN inducibility, previously not reported for other IFN-stimulable promoters.


Subject(s)
Antigens, Nuclear , Autoantigens/biosynthesis , Autoantigens/genetics , Interferon-gamma/pharmacology , Nuclear Proteins/biosynthesis , Nuclear Proteins/genetics , Promoter Regions, Genetic , Transcription, Genetic/drug effects , Base Sequence , Binding Sites , Burkitt Lymphoma , Chloramphenicol O-Acetyltransferase/biosynthesis , Gene Expression/drug effects , Genes, Reporter , Genomic Library , HeLa Cells , Humans , Interferon-beta/pharmacology , Molecular Sequence Data , Promoter Regions, Genetic/drug effects , Protein Biosynthesis , RNA, Messenger/biosynthesis , Recombinant Proteins/biosynthesis , Transcription Factors/metabolism , Transfection , Tumor Cells, Cultured
5.
Eur J Biochem ; 238(2): 554-60, 1996 Jun 01.
Article in English | MEDLINE | ID: mdl-8681971

ABSTRACT

Promyelocytic leukemia protein (PML) and Sp100 are transcription-regulatory proteins which colocalize in discrete nuclear dots and play a role in autoimmunity, oncogenesis and virus-host interaction. Interferons (IFNs) were shown previously to increase strongly the levels of Sp100 mRNA and protein. Here, we examined which mechanisms lead to upregulation of Sp100 gene expression and whether IFNs also increase expression of the promyelocytic leukemia (PML) gene. We found that both mRNA and protein levels of PML are also strongly upregulated by IFNs. In addition, new Sp100 and PML proteins were detected immunologically after IFN treatment of cells. Nuclear run-on analysis revealed protein-synthesis-independent, rapid IFN-enhanced transcription rates as well as synergistic activation of the Sp100 and PML genes by type-I and type-II IFNs. These data demonstrate that PML and Sp100 belong to the growing family of IFN-stimulated genes (ISGs) upregulated most likely by the transcription factor ISGF3, and indicate that IFNs also qualitatively alter the expression of these two genes.


Subject(s)
Antigens, Nuclear , Autoantigens/genetics , Gene Expression Regulation, Neoplastic , Interferon-beta/pharmacology , Interferon-gamma/pharmacology , Neoplasm Proteins , Nuclear Proteins/genetics , Transcription Factors/genetics , Autoantigens/biosynthesis , Blotting, Northern , Cycloheximide/pharmacology , HeLa Cells , Humans , Immunoblotting , Kinetics , Nuclear Proteins/biosynthesis , Promyelocytic Leukemia Protein , Protein Synthesis Inhibitors/pharmacology , RNA, Messenger/metabolism , Transcription Factors/biosynthesis , Transcription, Genetic , Tumor Suppressor Proteins
6.
Mol Cell Biol ; 16(3): 1150-6, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8622659

ABSTRACT

In human cells, three proteins are currently known to colocalize in di screte nuclear domains (designated nuclear dots): Sp100, a transcription-activating protein autoantigenic primarily in patients with primary biliary cirrhosis; PML, a tumor suppressor protein involved in development of acute promyelocytic leukemia; and NDP52, a protein of unknown function. Here we report sequence similarities between the Sp100 protein and a putative protein encoded by a highly amplified mouse gene which is visible as an inherited homogeneously staining region (HSR) on chromosome 1 of some mouse populations. By in situ hybridization, the Sp100 gene was mapped to locus 2q37, the syntenic region of the HSR on mouse chromosome 1. Unlike the highly amplified mouse gene, Sp100 was found to be a single-copy gene and showed no restriction fragment length polymorphisms. Sequence similarities in the promoter regions and similar exon-intron organizations of the two genes were revealed. As for Sp100, steady-state levels of the mRNAs of the HSR-encoded genes could be greatly increased by interferon (IFN) treatment. As in human cells, IFN treatment led to an enlargement in both size and number of nuclear dots in mouse cells as visualized by immunofluorescence staining with autoimmune sera from patients with primary biliary cirrhosis. These data indicate that a gene located in the inherited HSR of mice, designated mSp100, is homologous to the human Sp100 gene, has a similar gene organization, and responds similarly to IFN treatment.


Subject(s)
Antigens, Nuclear , Autoantigens/genetics , Chromosome Banding , Nuclear Proteins/genetics , 3T3 Cells , Amino Acid Sequence , Animals , Autoantigens/biosynthesis , Base Sequence , Chromosome Mapping , Cloning, Molecular , Gene Amplification , Humans , Interferons/pharmacology , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Multigene Family , Nuclear Proteins/biosynthesis , Sequence Alignment , Sequence Homology, Amino Acid
7.
Scand J Immunol ; 42(2): 257-68, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7631159

ABSTRACT

The nucleoproteins Sp100 and PML, the first an autoantigen predominant in patients with primary biliary cirrhosis (PBC) and the second a transformation and cell growth suppressing protein aberrantly expressed in promyelocytic leukaemia cells, were recently shown to colocalize in dot-like nuclear domains. Here we analysed whether PML, like Sp100, is also an autoantigen in patients with PBC and other autoimmune diseases, and wether both proteins interact directly. Testing sera from autoimmune patients using an immunoprecipitation assay with radiolabelled PML and an immunofluorescence assay based on a cell line overexpressing PML, autoantibodies (Aabs) against PML were found in the majority o anti-Sp100 Aab positive patients. Only very few patients with PBC or other autoimmune diseases contained anti-PML or anti-Sp100 Aabs exclusively. In contrast to Sp100, immunoreactivity of recombinant PML in immunoblots was only weak and was directed to one region. This suggests that anti-PML Aabs recognize fewer and preferentially conformation-dependent epitopes. In an immunoprecipitation assay using in vitro synthesized Sp100 and PML proteins and Abs to recombinant proteins, no direct interaction was observed. Taken together, these data indicate that Aabs against PML are as highly prevalent and specific for patients with PBC as those against Sp100. The colocalization of these autoantigens and the frequent co-occurrence of the corresponding Aabs might reflect an association of both proteins mediated by one or several other proteins.


Subject(s)
Autoantibodies/immunology , Liver Cirrhosis, Biliary/immunology , Neoplasm Proteins , Transcription Factors/immunology , Autoantibodies/blood , Cell Line, Transformed , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Transfer Techniques , Humans , Nuclear Proteins/immunology , Promyelocytic Leukemia Protein , Transcription Factors/genetics , Tumor Suppressor Proteins
8.
J Immunol ; 149(12): 4067-73, 1992 Dec 15.
Article in English | MEDLINE | ID: mdl-1281200

ABSTRACT

About 30% of patients suffering from the chronic autoimmune liver disease primary biliary cirrhosis produce autoantibodies against Sp100, a protein migrating in SDS-PAGE at a position corresponding to 100 kDa and located on discrete dot-shaped nuclear structures. The human Sp100 cDNA has recently been cloned and the deduced amino acid sequence was found to contain similarities to several transcriptional regulatory proteins; the biologic function of the Sp100 protein, however, is still unknown. In this study we present data which show that infection of HEp2 cells with influenza A virus, transformation of glial cells with SV40 DNA, and stimulation of PBL with mitogens affect the expression of the Sp100 autoantigen. These observations prompted us to investigate whether expression of the Sp100 protein is modulated by the action of IFN. Immunofluorescence staining of HEp2 and HeLa cells grown in the presence of IFN-alpha, IFN-beta, or IFN-gamma revealed an increase both in size and number of the Sp100 protein-containing nuclear dots, whereas no such effect was observed with cells treated with TNF-alpha. As measured by an immunoblot-based ELISA the amount of Sp100 protein in INF-beta-treated cells (1000 IU/ml, 18 h) was eight to nine times higher than in untreated cells. The enhanced protein expression was accompanied by an accumulation of the Sp100-specific mRNA (13-fold increase of the normal level after 10 h of INF-beta treatment of HEp2 cells). These findings characterize the Sp100 protein as a new member of IFN-modulated proteins and raise the question whether cytokine-mediated increase of Sp100 protein expression plays a role in induction of anti-Sp100 autoantibodies.


Subject(s)
Antigens, Nuclear , Autoantigens/biosynthesis , Gene Expression Regulation/immunology , Interferons/physiology , Liver Cirrhosis, Biliary/immunology , Nuclear Proteins/biosynthesis , Animals , Base Sequence , Blotting, Northern , Blotting, Western , Cell Transformation, Viral , Cells, Cultured , Humans , Influenza A virus/immunology , Interferon-alpha/physiology , Interferon-beta/physiology , Interferon-gamma/physiology , Mice , Microscopy, Fluorescence , Molecular Sequence Data , RNA, Messenger/biosynthesis , Simian virus 40/immunology , Time Factors
9.
Virology ; 187(1): 383-7, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1736543

ABSTRACT

There is increasing evidence for selection of hepatitis B virus (HBV) mutants during the natural course of infection, after immunization, and during interferon therapy. These mutants can prolong viral persistence, escape immune-mediated elimination, and influence the clinical sequelae of infection. Here we describe a sensitive and reliable method that allows detection of HBV mutants within a heterogeneous virus population. The method consists of amplification of HBV DNA with vector-HBV hybrid primers, efficient and enzyme-free cloning of the amplified DNA fragment, identification by hybridization with synthetic oligonucleotide probes, and sequencing of the cloned DNA fragments. We demonstrate that up to 10(5) HBV DNA fragments can be obtained in cloned form from a single amplification reaction, the ratio of HBV pre-C "wild-type" and mutant sequences of heterogeneous populations can be determined, and very minor virus subpopulations can be identified. The method can be applied to other viral or nonviral nucleic acid sequence variation studies and should help to resolve the role of mutant and wild-type viruses in pathogenesis and the forces driving their selection.


Subject(s)
Cloning, Molecular/methods , Hepatitis B virus/genetics , Mutation/genetics , Base Sequence , DNA, Viral/genetics , Molecular Sequence Data , Nucleic Acid Hybridization , Polymerase Chain Reaction
10.
Gastroenterology ; 102(2): 538-43, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1732124

ABSTRACT

The type of hepatitis B virus ("wild-type" or precore mutant) in anti-e antigen antibody-positive carriers, viral DNA levels in the serum, and core and e antigen expression in the liver were investigated to search for a possible correlation of these factors with the severity of liver damage. Two major groups of patients were found: the patients in group A were predominantly infected with precore mutant virus and had chronic active hepatitis, expressed nuclear/cytoplasmic core and e antigens in liver biopsy specimens, and usually had high levels of viral DNA in their serum; patients in group B were infected with a mixture of wild-type and mutant viruses, had predominantly chronic persistent hepatitis, showed weaker expression of nuclear core antigen with no cytoplasmic core or e antigen, and had low viremia. A few patients were infected with viruses without precore stop-codon mutation. These data indicate a high prevalence of precore mutant viruses in anti-e carriers with chronic liver disease and suggest that monitoring of virus sequence type and DNA level may be of prognostic value for liver disease sequelae.


Subject(s)
Hepatitis B Antigens/blood , Hepatitis B virus/classification , Hepatitis B/complications , Liver Diseases/microbiology , Adult , Amino Acid Sequence , Base Sequence , Chronic Disease , DNA, Viral/blood , Female , Hepatitis B Core Antigens/blood , Hepatitis B e Antigens/blood , Hepatitis B virus/genetics , Hepatitis B virus/immunology , Humans , Liver Diseases/blood , Liver Diseases/pathology , Male , Middle Aged , Molecular Sequence Data , Mutation , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...